INEGY 10 MG80 MG TABLETS

Country: Israel

Bahasa: Inggeris

Sumber: Ministry of Health

Bahan aktif:

EZETIMIBE; SIMVASTATIN

Boleh didapati daripada:

MERCK SHARP & DOHME ISRAEL LTD

Kod ATC:

C10AA01

Borang farmaseutikal:

TABLETS

Komposisi:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Laluan pentadbiran:

PER OS

Jenis preskripsi:

Required

Dikeluarkan oleh:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Kumpulan terapeutik:

SIMVASTATIN

Kawasan terapeutik:

SIMVASTATIN

Tanda-tanda terapeutik:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Tarikh kebenaran:

2012-04-30